I-MAK co-director and co-founder Priti Krishtel gives her thoughts on AbbVie’s Mavyret— the latest hepatitis C treatment— sharing her concerns about pricing and access.
I-MAK co-director and co-founder Priti Krishtel gives her thoughts on AbbVie’s Mavyret— the latest hepatitis C treatment— sharing her concerns about pricing and access.
Learn more about how you can help build a more equitable system for all